Activation of the interferon pathway in trophoblast cells productively infected with SARS-CoV-2.

SARS-CoV-2 infection during pregnancy has been associated with poor maternal and neonatal outcomes and placental defects. The placenta, which acts as a physical and immunological barrier at the maternal/fetal interface, is not established until the end of the first trimester. Therefore, localized viral infection of the trophoblast compartment early in gestation could trigger an inflammatory response resulting in altered placental function and consequent suboptimal conditions for fetal growth and development. In this study, we investigated the effect of SARS-CoV-2 infection in early gestation placentae using placenta-derived human trophoblast stem cells (TSC), a novel in vitro model, and their extra-villous trophoblast (EVT) and syncytiotrophoblast (STB) derivatives. SARS-CoV-2 was able to productively replicate in TSC-derived STB and EVT, but not undifferentiated TSC, which is consistent with the expression of SARS-CoV-2 entry host factors, ACE2 and TMPRSS2 in these cells. In addition, both TSC-derived EVT and STB infected with SARS-CoV-2 elicited an interferon-mediated innate immune response. Combined, these results suggest that placenta derived TSCs are a robust in vitro model to investigate the effect of SARS-CoV-2 infection in the trophoblast compartment of the early placenta and that SARS-CoV-2 infection in early gestation activates the innate immune response and inflammation pathways. Therefore, placental development could be adversely affected by early SARS-CoV-2 infection by via directly infecting the developing differentiated trophoblast compartment, posing a higher risk for poor pregnancy outcomes.

[1]  S. Dietmann,et al.  Stem-cell-derived trophoblast organoids model human placental development and susceptibility to emerging pathogens. , 2022, Cell stem cell.

[2]  M. Diamond,et al.  Innate immunity: the first line of defense against SARS-CoV-2 , 2022, Nature Immunology.

[3]  H. Smits,et al.  Microbiota and compartment matter in the COVID-19 response , 2021, Nature Immunology.

[4]  L. Laurent,et al.  Transcriptomic Drivers of Differentiation, Maturation, and Polyploidy in Human Extravillous Trophoblast , 2021, Frontiers in Cell and Developmental Biology.

[5]  D. Roberts,et al.  SPECIAL REPORT: A standardized definition of placental infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a consensus statement from the National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD) SARS-CoV-2 placen , 2021, American Journal of Obstetrics and Gynecology.

[6]  M. Koopmans,et al.  Unique Severe COVID-19 Placental Signature Independent of Severity of Clinical Maternal Symptoms , 2021, Viruses.

[7]  Y. Mekki,et al.  Placental lesions and SARS-Cov-2 infection: Diffuse placenta damage associated to poor fetal outcome , 2021, Placenta.

[8]  G. Gao,et al.  Cell entry by SARS-CoV-2 , 2021, Trends in Biochemical Sciences.

[9]  F. Crispi,et al.  Diffuse trophoblast damage is the hallmark of SARS-CoV-2-associated fetal demise , 2021, Modern Pathology.

[10]  J. Schultze,et al.  COVID-19 and the human innate immune system , 2021, Cell.

[11]  R. Redline,et al.  Four major patterns of placental injury: a stepwise guide for understanding and implementing the 2016 Amsterdam consensus , 2021, Modern Pathology.

[12]  M. Puri,et al.  COVID-19 as an independent risk factor for subclinical placental dysfunction , 2021, European Journal of Obstetrics & Gynecology and Reproductive Biology.

[13]  K. Mertz,et al.  Placental Pathology Findings during and after SARS-CoV-2 Infection: Features of Villitis and Malperfusion , 2020, Pathobiology.

[14]  L. Mofenson,et al.  Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis , 2020, BMJ.

[15]  F. Kirchhoff,et al.  IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro , 2020, Nature Communications.

[16]  Adam Hage,et al.  TRIM Proteins in Host Defense and Viral Pathogenesis , 2020, Current Clinical Microbiology Reports.

[17]  A. Iwasaki,et al.  The Role of Immune Factors in Shaping Fetal Neurodevelopment. , 2020, Annual review of cell and developmental biology.

[18]  M. Smithgall,et al.  Third‐trimester placentas of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐positive women: histomorphology, including viral immunohistochemistry and in‐situ hybridization , 2020, Histopathology.

[19]  N. Schmidt,et al.  Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19 , 2020, Frontiers in Immunology.

[20]  Mohammed S. Alqahtani,et al.  Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective , 2020, International Journal of Biological Macromolecules.

[21]  J. Goldstein,et al.  Placental Pathology in COVID-19 , 2020, American journal of clinical pathology.

[22]  A. Iwasaki,et al.  Contributions of maternal and fetal antiviral immunity in congenital disease , 2020, Science.

[23]  A. Spanevello,et al.  The pivotal link between ACE2 deficiency and SARS-CoV-2 infection , 2020, European Journal of Internal Medicine.

[24]  Mandeep R. Mehra,et al.  COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal , 2020, The Journal of Heart and Lung Transplantation.

[25]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[26]  Alireza Hadj Khodabakhshi,et al.  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.

[27]  B. Slobedman,et al.  Interferon-Independent Upregulation of Interferon-Stimulated Genes during Human Cytomegalovirus Infection is Dependent on IRF3 Expression , 2019, Viruses.

[28]  M. Suyama,et al.  Derivation of Human Trophoblast Stem Cells. , 2018, Cell stem cell.

[29]  J. Kwon,et al.  Viral Infections During Pregnancy , 2015, American journal of reproductive immunology.

[30]  R. Romero,et al.  New Insights into the Relationship between Viral Infection and Pregnancy Complications , 2014, American journal of reproductive immunology.

[31]  F. Arechavaleta-Velasco,et al.  Adeno-associated virus-2 (AAV-2) causes trophoblast dysfunction, and placental AAV-2 infection is associated with preeclampsia. , 2006, The American journal of pathology.